SUTRO BIOPHARMA, INC.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
Business Address
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Mailing Address
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Phone
650-392-8412
Fiscal Year End
1231
EIN
452441988
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 23, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | March 23, 2026 | View on SEC |
| 8-K Current report of material events | March 23, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 18, 2026 | View on SEC |
Annual Reports
10-K
March 23, 2026
- Achieved significant sales growth in 2024, reaching $85.7 million, primarily driven by strong partnership revenues.
- Maintained a robust cash balance of $305.0 million by year-end 2024, providing a projected cash runway until mid-2026.
Related Companies
Companies in the same industry (SIC: 2836)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Quince Therapeutics, Inc.
QNCX
Biological Products, (No Diagnostic Substances)
Hemab Therapeutics Holdings, Inc.
Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
MESOBLAST LTD
MESO
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.